Low-Dose Naltrexone for Severe Fibromyalgia Syndrome: A Report of a Case With Two-Year Follow-Up
Ulrich Moser
[Line breaks added]
Abstract
Fibromyalgia syndrome (FMS) is characterized by diffuse musculoskeletal pain associated with daytime fatigue, sleep disturbance, cognitive deficits, and...
Abstract
Low-dose naltrexone (LDN) has demonstrated mixed efficacy in treating fibromyalgia. This systematic review and meta-analysis aimed to evaluate the efficacy of LDN for fibromyalgia. We systematically searched electronic databases and gray literature from inception to May 2024. Included...
Hi,
I am curious as to whether anyone has some developed hypotheses as to the mechanism of 'low-dose' Naltrexone?
Much of the discourse about Naltrexone is dominated by discussion of it being a competitive inhibitor of the function of of mu-opioid receptors.
But it is known that at lower...
Abstract
Introduction:
Fibromyalgia (FM) is a chronic fluctuating, nociplastic pain condition. Naltrexone is a µ-opioid-receptor antagonist; preliminary studies have indicated a pain-relieving effect of low-dose naltrexone (LDN) in patients with FM. The impetus for studying LDN is the...
Clinical trial registration.
There is a growing number of individuals who do not recover to previous levels of health and function following an acute infection by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), but rather develop what has been referred to as 'Long-COVID'...
Full title: Potential therapeutic benefit of Low Dose Naltrexone in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Role of Transient Receptor Potential Melastatin 3 ion channels in pathophysiology and treatment
Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is a debilitating...
Source: Solve ME/CFS Initiative
Date: December 13, 2018
Time: 18:00-19:00 UTC
URL: https://register.gotowebinar.com/register/1541028613190392835
ME/CFS Involves Brain Inflammation: Results from a Ramsay Pilot Study
----------------------------------------------------------
Presented by...
[I'm not impressed with the way the abstract for this study is written]
https://www.tandfonline.com/doi/full/10.1080/21641846.2018.1477034
Original Articles
Double-blinded placebo-controlled cross-over pilot trial of naltrexone to treat Gulf War Illness
Kori L. Brewer...
Abstract
A patient with severe postural orthostatic tachycardia syndrome (POTS) and mast cell activation syndrome (MCAS) received immunotherapy with low-dose naltrexone (LDN) and intravenous immunoglobulin (IVIg) and antibiotic therapy for small intestinal bacterial overgrowth (SIBO). A dramatic...
Ive started to get all over muscle pain back again and bad headaches. This is frustrating as I used to get this a lot (even when relatively mild) but it had more or less gone. It is bad enough to disturb my sleep.:(
In the past I used to take amitriptyline to help regulate my body clock. If you...
Threads about articles and people's experiences with LDN have been merged into this single thread.
Medscape: Low-dose Naltrexone Explored as Option for Chronic Pain (by Miriam Tucker)
Miriam Tucker's third article from the recent 2- day summit at the Bateman-Horne Center
Low-dose Naltrexone...
This interview was published on Oct 11, 2017. I haven't seen it posted elsewhere.
Haven't read it yet but it has a contents list!
Introduction
Leptin and Chronic Fatigue Syndrome
Neuroinflammation and Autoimmunity
Blood Tests for Pain and Fatigue
Gut Inflammation
Blood Pressure
Visual...
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.